cataract
Conditions
Interventions
1:phacoemulsification with posterior chamber intraocular lens implantation
2:the patients undergoing phacoemulsification with posterior chamber intraocular lens implantation received ophthalmic bromfenac sodium 0.1% twice per day for 1 month
3:femtosecond laser assisted phacoemulsification with posterior chamber intraocular lens implantation
Sponsors
the 4th Affiliated Hospital, China Medical University
Eligibility
Sex/Gender
All
Age
45 Years to 90 Years
Inclusion criteria
Inclusion criteria: age-related cataract patients undergoing phacoemulsification with posterior chamber intraocular lens implantation
Exclusion criteria
Exclusion criteria: 1. patients who were suffering from any ocular diseases that might affect treatment responses or evaluations, such as corneal disease, glaucoma, uveitis, retinal detachment, optic neuropathy or amblyopia; 2. patients who were suffering with any systemic diseases that might affect treatment responses or evaluations, such as diabetes mellitus; 3. patients who were suffering from nystagmus and the pupil size which is fixed with less than 6mm; 4. patients who had received systemic or topical anti-inflammatory therapy within 1 month prior to surgery; 5. patients who had sevese dysfunction of heart, liver and kidney; 6. potentially pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Aqueous Prostaglandin E2 level; | — |
Secondary
| Measure | Time frame |
|---|---|
| pupil size;ocular pressure;macular thickness; | — |
Contacts
Public ContactJin-song Zhang
Outcome results
None listed